Should research that makes pathogens more deadly or infectious—or other dangerous research—be conducted in the first place?
Should research that makes pathogens more deadly or infectious—or other dangerous research—be conducted in the first place?
This week will mark the one-year anniversary of the last polio case in the second-most populous country.
The discredited physician, who falsely reported a link between autism and vaccines, has filed a new libel claim.
An adenovirus isolated from chimpanzee feces proves more effective than human adenoviruses as a vaccine vector for hepatitis C.
A new Ebola vaccine candidate protects mice against death and can be produced quickly in response to a bioterrorism threat.
A genetically engineered smallpox vaccine improved the survival of liver cancer patients participating in a phase II clinical trial.
Platelets play a role in capturing bacteria and initiating an immune response against them.
Scientists are questioning the results of a malaria vaccine trial that were released last week.
Inadequate poultry immunization programs may cause higher mutations rates in the bird flu virus, rendering the vaccine ineffective and increasing the threat of cross-species transmission.